Synthesis of Hoechst 33258 analogues designed to target human tumor helicases

Heterocyclic Communications

Volumn 5, Issue 1, 1999, Pages 11-18

  Singh, Ashok K ^a   Lown, J William ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033447089     PISSN: 07930283     EISSN: None     Source Type: Journal    
DOI: 10.1515/HC.1999.5.1.11     Document Type: Article

References (27)

1. a) W. Muller and F Gautier, and F Gautier, Eur. J. Biochem., 54, 385 (1975);
2. b) C Zimmer, and U. Wahnert, Prog. Biophys. Mol. Biol., 47, 31-112 (1986);
3. c) V. Murray, and R.F. Matin, J. Mol. Biol., 201, 437-442 (1988)
4. a) K.D. Harshman and P.B. Dervon, Nucleic Acids Res., 13, 4825-4835 (1985);
5. b) R.E. Dickerson, M.L. Kopka and P.E. Pjura, In DNA - ligand interactions from Drugs to proteins ed. by W. Guschlbauer and W. Saenger, Plenum: New York, 1987 pp. 45-54.
6. P.E. Pjura, I. Grzeskowiak and R.E. Dickerson, J. Mol. Biol., 197, 257 (1987)
7. M-K. Teng, N. Usman, C.A. Frederick and A.H.J Wang; Nucleic Acids Res., 16, 2671 (1988)
8. J.A. Parkinson, J. Barber, K.T. Douglas, J. Rosamund and D. Sharpless Biochemistry, 29, 10181 (1990)
9. M.S. Searle, K.J. Embrey, Nucleic Acids Res., 18, 3753 (1990)
10. A. Fede, A. Labhardt, W. Bannwarth, W. Leupin; Biochemistry, 30, 11377 (1991)
11. D. Goodsell and R.E. Dickerson, J. Med. Chem., 29, 727-733 (1986)
12. T. Lin, B. Teicher and A. Sartorelli, J. Med. Chem., 23, 1237 (1980)
13. a) H.W. Moore, Science (Washington, D.C.) 197, 527 (1977);
14. b) H.W. Moore and R. Czerniak, Med. Res. Rev., 1, 249 (1981)
15. a) E.B. Skibo, J. Org. Chem., 51, 522 (1986);
16. b) C.H. Lee, E.B. Skibo, Biochemistry, 26, 7355 (1987);
17. c) R.H. Lemus, C.H. Lee and E.B. Skibo, J. Org. Chem., 54, 3611 (1989);
18. d) E.B. Skibo, J. Org. Chem., 1992, 57, 5874 (1989)
19. a) S.A. Everett, M.A. Naylor, J. Nolan, K.B. Patel and P. Wardman, Anti-Cancer Drug Design, 13, 635-653 (1998);
20. b) C.J. Moody, C.L. Norton, A.M.Z. Slawin and S. Taylor, Anti-Cancer Drug Design, 13, 611-634 (1998)
21. R. Zhao and J.W. Lown, Heterocycl. Commun., 4, 11-19 (1998)
22. L. Guan, R. Zhao and J.W. Lown, Biochem. Biophys. Res. Commun., 231, 94-98 (1997)
23. K-J. Soderlind, B. Sorodetsky, A.K. Singh, N.R. Baucher, G.G. Miller and J.W. Lown, Anti-Cancer Drug Design, in press (1998)
24. A.K. Singh and J.W. Lown, Synth. Commun., 28, 4059-4066 (1998)
25. Y. Bathini and J.W. Lown, Synth. Commun., 20, 955-963 (1990)
26. J.F.W. McOmie, M.L. Watts and D.E. West, Tetrahedron, 24, 2289-2292 (1968)
27. Jung S. Kim, Q. Sun, C. Yu, A. Liu, L.F. Liu and E.J. Lavoie, Bioorg. Med. Chem., 6, 163-172 (1998)